The role of the N-methyl-D-aspartate receptor NR1 subunit in peripheral nerve injury-induced mechanical allodynia, glial activation and chemokine expression in the mouse

Neuroscience

Volumn 125, Issue 1, 2004, Pages 269-275

  Bursztajn, S ^a   Rutkowski, M D ^a   Deleo, J A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Astrocyte; COX 2; Cyclooxygenase 2; GFAP; Glial fibrillary acidic protein; Glutamate; Inducible protein 10; IP 10; L5; Lumbar 5 spinal segment; MCP; Microglia; MIP; Monocyte chemoattractant protein; Monocyte inducible protein; Neuropathic pain; NMDA; Spinal cord

Indexed keywords

CHEMOKINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; RIBONUCLEASE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION; GENETIC ENGINEERING; GLIA CELL; HYPERSENSITIVITY REACTION; IMMUNOHISTOCHEMISTRY; INSTRUMENTATION; KNOCKOUT MOUSE; METHODOLOGY; MOUSE; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NERVE INJURY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR GENE; SPINAL CORD; SPINAL PAIN; TIME;

ANIMALS; AXOTOMY; BLOTTING, WESTERN; CHEMOKINES; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; LUMBOSACRAL REGION; MICE; MICE, KNOCKOUT; NEUROGLIA; PAIN; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SPINAL NERVES;

EID: 1642421156     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.01.024     Document Type: Article

References (38)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino A.J., MacIntyre D.E., Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA. 100:2003;7947-7952.
2. Allen N.J., Attwell D. A chemokine-glutamate connection. Nat Neurosci. 4:2001;676-678.
3. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNFa Amplification by microglia triggers neurotoxicity. Nat Neurosci. 4:2001;702-710.
4. Bursztajn S, Feng JJ, Iwasato T, Berman SA, Tonegawa S, Nanda A (1999) Functional N-methyl-D-aspartate (NMDARs) are necessary for the initiation of apoptosis in cortical cells. Soc Neurosci Abstr. 683.13:1719.
5. Chu LM, Nichols R, Berman SA, Griffin M, Roy KM, Bursztajn S (2002) Protein kinase C (PKC) expression is dependent on NMDA receptor activity. Soc Neurosci Abstr.
6. Coderre T., Van Empel I. The utility of excitatory amino acid (EAA) antagonists as analgesic agents I. comparison of the antinociceptive activity of various classes of eaa antagonists in mechanical, thermal and chemical nociceptive tests. Pain. 59:1994;345-352.
7. Colburn R.W., DeLeo J.A., Rickman A.J., Yeager M.P., Kwon P., Hickey W.F. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol. 79:1997;163-175.
8. Colburn R.W., Rickman A.J., DeLeo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol. 157:1999;289-304.
9. Coughlan C., McManus C.M., Sharron M., Gao Z., Murphy D., Jaffer S., Choe W., Chen W., Hesselgesser J., Gaylord H., Kalyuzhny A., Lee V.M.Y., Wolf B., Doms R.W., Kolson D.L. Expression of multiple functional chemokines receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience. 97:2000;591-600.
10. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits Diversity, development, and disease. Curr Opin Neurobiol. 11:2001;327.
11. DeLeo J.A., Rutkowski M.D., Stalder A.K., Campbell I.L. Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport. 11:2000;599-602.
12. DeLeo J.A., Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain. 90:2001;1-6.
13. DeLeo JA, Winkelstein BA, Rutkowski MD (2002) The modulatory role of spinal chemokine activation in neuropathic pain. Society for Neuroscience 32nd Annual Meeting, Orlando, FL, abstract number 655.16.
14. Dickenson A., Chapman V., Green G. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol. 28:1997;633-638.
15. Didier M., Xu M., Berman S.A., Saido T.C., Bursztajn S. Involvement of three glutamate receptor epsilon subunits in the formation of N-methyl-D-aspartate receptors mediating excitotoxicity in primary cultures of mouse cerebellar granule cells. Neuroscience. 2 78:1997;1129-1146.
16. Du J., Zhou S., Coggeshall R.E., Carlton S.M. N-methyl-D-aspartate- induced excitation and sensitization of normal and inflamed nociceptors. Neuroscience. 118:2003;547-562.
17. Enarson M.C., Hays H., Woodroffe M.A. Clinical experience with oral ketamine. J Pain Symptom Manag. 17:1999;384-386.
18. Glabinski A.R., Balasingam V., Tani M., Kunkel S.L., Streiter R.M., Yong V.W., Ransohoff R.M. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol. 156:1996;4363-4368.
19. Gourmala N.G., Buttini M., Limonta S., Sauter A., Boddeke H.W. Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain Effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol. 74:1997;35-44.
20. Hollmann M, Jonas P, Monyer H, eds. Springer Verlag (1999) Structure of ionotropic glutamate receptors. Hand Exp Pharmacol 141:3-98.
21. Iwasato T., Erzurumulu R.S., Huerta P.T., Chen D.F., Sasaoka T., Tonegawa S. NMDA receptor-dependent refinement of somatotropic maps. Neuron. 19:1997;1201-1210.
22. Klepstad P., Maurset A., Moberg E.R., Oye I. Evidence of a role for NMDA receptors in pain perception. Eur J Pharmacol. 187:1990;513-518.
23. Kristensen J.D., Svensson B., Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain. 51:1992;249-253.
24. Lax P., Limatola C., Fucile S., Trettel F., Di Bartolomeo S., Renzi M., Ragozzino D., Eusebi F. Chemokine receptor CXCR2 regulates the functional properties of AMPA-type glutamate receptor GluR1 in HEK cells. J Neuroimmunol. 129:2002;66-73.
25. Li J., Berman S.A., Messer A., Nixon R.A., Bursztajn S. Altered gene expression for calpain/calpastatin sytem in motor neuron degeneration (Mnd) mutant brain and spinal cord. Mol Brain Res. 53:1998;174-186.
26. Li Y., Erzurumlu R., Chen C., Jhavari S., Tonegawa S. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell. 76:1994;427-443.
27. Mao J., Price D.D., Lu J., Mayer D.J. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. Neurosci Lett. 250:1998;193-196.
28. Mao J. NMDA and opioid receptors Their interactions in antinociception, tolerance and neuroplasticity. Brain Res Brain Res Rev. 30:1999;289-304.
29. Milligan E.D., O'Connor K.A., Nguyen K.T., Armstrong C.B., Twining C., Gaykema R.P., Holguin A., Martin D., Maier S.F., Watkins L.R. Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci. 21:2001;2808-2819.
30. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 34:1995;1219-1237.
31. Price D.D., Mayer D.J., Mao J., Caruso F.S. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage. 19:(1 Suppl):2000;S7-11.
32. Rabben T., Skjelbred P., Oye I. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther. 289:1999;1060-1066.
33. Rutkowski M., Winkelstein B.A., Hickey W.F., Pahl J., DeLeo J.A. Lumbar root injury induces CNS neuroinflammation and neuroimmune activation in the rat Relationship to painful radiculopathy. Spine. 27:2002;1604-1613.
34. Schmid R.L., Sandler A.N., Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain A review of current techniques and outcomes. Pain. 82:1999;111-125.
35. South S.M., Kohno T., Kaspar B.K., Hegarty D., Vissel B., Drake C.T., Ohata M., Jenab S., Sailer A.W., Malkmus S., Masuyama T., Horner P., Bogulavsky J., Gage F.H., Yaksh T.L., Woolf C.J., Heinemann S.F., Inturrisi C.E. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci. 23:2003;5031-5040.
36. Sweitzer S., Hickey W.F., DeLeo J.A. Focal nerve injury induces leukocyte trafficking into the CNS Relationship to neuropathic pain. Pain. 100:2002;163-170.
37. Winkelstein B.A., Rutkowski M., Sweitzer S., Pahl J.L., DeLeo J.A. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacological treatment. J Comp Neurol. 439:2001;127-139.
38. Woolf C.J., Costigan M. Transcriptional and post translational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA. 96:1999;7723-7730.